Izvorni znanstveni članak

N-Sulfonylpyrimidine derivatives and hyperthermia treatment of anaplastic mammary carcinoma in vivo

Marina Pavlak orcid.org/0000-0003-0618-0199 ; Department of Veterinary Economics and Analytic Epidemiology, Faculty of Veterinary Medicine, Zagreb University, Zagreb, Croatia
Marko Radačić ; Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia
Ranko Stojković ; Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia
Biserka Žinić ; Division of Organic Chemistry and Biochemistry, Ruđer Bošković Institute, Zagreb, Croatia

Sažetak

The aim of this study was to investigate in vivo antitumor activity of newly synthesized N-sulfonylpyrimidine derivatives applied as a single agent and in combination with hyperthermia (43 oC/60 min). Antitumor activity was examined for: 1-(p-toluenesulfonyl)cytosine (4H), 1-(p-toluenesulfonyl)cytosine hydrochloride (4HxHCl),
complex (Zn(II) [1-(p-toluenesulfonyl)cytosine]2) (4K) and 5-bromo-1-(methanesulfonyl)uracil (8H). In the study we used transplantable anaplastic mammary carcinoma (AMCa). All experiments were performed on 10-14-week-old female CBA mice weighing 22-25 g at the time of treatment. The obtained data show that N-sulfonylpyrimidine derivatives (4H, 4HxHCl, 4K, 8H) possess antitumor activity. In combination with hyperthermia, the highest enhancement was obtained when hyperthermia was applied with 4HxHCl (300 mg/kg). The antitumor activity of N-sulfonylpyrimidine derivatives was similar or better than the antitumor effect of 5-fluorouracil (positive control). These findings provide a good reason for further research of these compounds, both in experimental and preclinical studies.

Ključne riječi

hyperthermia; mammary carcinoma; mice; N-sulfonylpyrimidine derivatives

Hrčak ID:

56719

URI

https://hrcak.srce.hr/56719

Datum izdavanja:

26.4.2010.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.101 *